NCT07627022Not yet recruiting
Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung Cancer
Source: ClinicalTrials.gov · Last updated 4 Jun 2026
Brief summary (registry, in English)
The primary objective of this prospective randomized trial is to explore whether the use of a smart phone-based reminder application is associated with a change in physical activity during radiation therapy in patients with lung cancer. The primary endpoint focuses on the within-patient change in physical activity between Week 1 and Week 5, with comparison between treatment groups to assess potential differences attributable to the intervention. Secondary objectives include the exploratory assessment of patient satisfaction with the reminder app, its impact on the use and perception of digital health technology. A total of 28 evaluable patients in the Full Analysis Set (approximately 14 per treatment arm) are required to detect a clinically relevant difference corresponding to a probability of superiority of approximately 0.65 with 80% power at a two-sided significance level of 0.05. Assuming that approximately 10% of patients will not be evaluable for the primary endpoint, a total of 32 patients will be randomized.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 31 May 2026
- Start date
- 1 Jul 2026
- Primary completion date
- 15 Feb 2027
- Lead sponsor
- University Hospital Schleswig-Holstein
- Diseases
- Lung cancer
- NCT number
- NCT07627022
What you commit to
- Study type: Interventional
- Planned participants: 32
- From 1 Jul 2026 to the primary completion date, 15 Feb 2027
- 7 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. Expected non-compliance
Who the study is looking for
- Histologically proven lung cancer
- Treatment with ≥50 Gy of conventionally fractionated radiation therapy
- Possession of and ability to use a smart phone plus a step counter
- Age ≥18 years
- Written informed consent
- Capacity of the patient to consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MVZ RON Niedersachsen Strahlentherapie GmbH Coordinator of this site? Confirm its status | Hanover | Germany | Unknown status |
| Department of Radiation Oncology, Christian-Albrechts University Coordinator of this site? Confirm its status | Kiel | Germany | Unknown status |
| Department of Radiation Oncology, University of Luebeck Coordinator of this site? Confirm its status | Lübeck | Germany | Unknown status |
| Department of Pulmonology, University of Luebeck Coordinator of this site? Confirm its status | Lübeck | Germany | Unknown status |
| Department of Oncology Vejle Hospital, University Hospital of Southern Denmark Coordinator of this site? Confirm its status | Vejle | Denmark | Unknown status |
| Radiation Oncology Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Department of Radiotherapy, Institute of Oncology Ljubljana and Faculty of Medicine, University of Ljubljana Coordinator of this site? Confirm its status | Ljubljana | Slovenia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.